Department of Paediatrics, School of Medical Sciences, Örebro University, Örebro, Sweden.
Department of Paediatrics, School of Medical Sciences, Örebro University, Örebro, Sweden,
Horm Res Paediatr. 2019;91(3):195-202. doi: 10.1159/000500265. Epub 2019 May 16.
We found an increase in the incidence rate (IR) of childhood thyrotoxicosis (CT) during the 1990s in central Sweden. The optimal treatment method for CT is a subject that is still debated upon.
To investigate whether the increase in IR of CT in Sweden persists and to study the treatment outcome.
Children <16 years of age diagnosed with CT during 2000-2009 and living in 1 of 5 counties in central Sweden were identified retrospectively using hospital registers. Data on clinical and biochemical characteristics and outcomes of treatment were collected from medical records. The corresponding data from 1990 to 1999 were pooled with the new data.
In total, 113 children were diagnosed with CT during 1990-2009 in the study area. The overall IR was 2.2/100,000 person-years (95% CI 1.2-2.5/100,000 person-years). The IR was significantly higher during 2000-2009 than during 1990-1999 (2.8/100,000 [2.2-3.6] vs. 1.6/100,000 person-years [1.2-2.2], p = 0.006). The increase was significant for both sexes. Seventy percent of the patients who completed the planned initial treatment with antithyroid drugs (ATDs) and were not lost to follow-up relapsed within 3 years. Boys tended to relapse earlier than girls (6.0 months after drug withdrawal [95% CI 1.9-10.0] vs. 12.0 months [95% CI 6.8-17.3], p = 0.074).
The IR of CT is increasing in both girls and boys. Relapse rate after withdrawal of ATD treatment is 70%. Boys tend to relapse earlier than girls, and this needs to be further investigated.
我们发现,在 20 世纪 90 年代,瑞典中部儿童甲状腺功能亢进症(CT)的发病率(IR)有所增加。CT 的最佳治疗方法仍是一个有争议的话题。
调查瑞典 CT 的 IR 增加是否持续,并研究治疗结果。
通过医院登记册,回顾性地确定了 2000-2009 年期间在瑞典中部 5 个县中诊断为 CT 的<16 岁儿童。从病历中收集了有关临床和生化特征以及治疗结果的数据。将 1990 年至 1999 年的数据与新数据合并。
在研究区域,共有 113 名儿童在 1990-2009 年期间被诊断为 CT。总发病率为 2.2/100,000人年(95%CI 1.2-2.5/100,000 人年)。2000-2009 年的发病率明显高于 1990-1999 年(2.8/100,000[2.2-3.6]比 1.6/100,000 人年[1.2-2.2],p=0.006)。男女发病率均有显著增加。完成抗甲状腺药物(ATD)计划初始治疗且未失访的患者中,有 70%在 3 年内复发。男孩停药后复发的时间早于女孩(停药后 6.0 个月[95%CI 1.9-10.0]比 12.0 个月[95%CI 6.8-17.3],p=0.074)。
女孩和男孩的 CT 发病率都在增加。ATD 治疗停药后的复发率为 70%。男孩停药后复发的时间早于女孩,这需要进一步研究。